Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

8

Revenue 2017

40

Revenue 2017

Enbrel

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Enbrel was produced by Amgen, Takeda and Pfizer.

BMS, Celgene merger should close this week after FTC okay

BMS, Celgene merger should close this week after FTC okay

Otezla slots nicely into Amgen’s existing psoriasis and anti-inflammatory portfolio, which includes TNF inhibitor Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s top-selling TNF blocker Humira (adalimumab).

Novartis expands its generics franchise with natalizumab biosimilar

Novartis expands its generics franchise with natalizumab biosimilar Sandoz has been the subject ofone such case, following a US court ruling in favour of Amgen regarding a dispute between the two companies over patents protecting Enbrel (etanercept) from biosimilar

Amgen snaps up Celgene’s Otezla for $13.4bn

Amgen snaps up Celgene’s Otezla for $13.4bn This includes Enbrel (boosted earlier this month by a successful defence of its US patent) and Amgevita, its Humira biosimilar, which is approved and already available in Europe and approved ahead

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan The ruling could delay the arrival of biosimilar competition for Enbrel in the US by a decade. ... Enbrel won FDA approval in 1998. Shares in Amgen rose 6% when news of the court ruling emerged.

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches” TNF inhibitor Enbrel (etanercept) also fell 5% in the face of competition from newer drugs in indications such as psoriasis.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics